At NeuroX, we’ve dedicated ourselves to transforming mental health using neurotech and evidence-based care.
Our clinics are a safe haven for individuals struggling with a wide range of mental health challenges, from anxiety and ADHD to trauma and cognitive decline.
What our patients say about their treatment experience:
• “After just a few sessions at NeuroX, my focus and confidence have improved drastically. I feel like I have control over my mind for the first time in years.”
• “The NeuroX team has changed my life. Their care and cutting-edge technology gave me hope when I thought none was left.”
• “I wish I’d found NeuroX earlier. The progress I’ve made here has been nothing short of extraordinary.”
Our work with patients has laid the foundation for Neve 1.0. By combining our clinical expertise with cutting-edge technology, we are poised to deliver a solution that is scalable, effective, and life-changing.
A Message from Anoop Antony, CEO of NeuroX
At NeuroX, we believe mental health care should both empower and prevent. With millions affected by late-diagnosed dementia, we face a global crisis that demands action.
Neve 1.0 is our bold solution - leveraging cutting-edge EEG and AI to detect dementia early and provide personalised therapy. It’s more than a product; it’s a movement to transform mental health care into proactive, accessible, and life-changing support. A step towards a future where early detection and personalised therapy are not luxuries but standards of care.
Dementia has quietly become a global crisis.
In the UK alone, dementia is now the leading cause of death, surpassing cancer and heart disease combined. With one-quarter of hospital beds occupied by people living with dementia, the cost to families and the healthcare system is immeasurable. Early detection is critical, yet current tools are expensive, inaccessible, or inadequate.
Enter Neve 1.0—a revolutionary digital health ecosystem.
At the heart of Neve 1.0 is our state-of-the-art EEG headband, a user-friendly app, and the Neural Cloud Platform, all seamlessly working together. Designed to screen for mild cognitive impairment (MCI) - a critical early stage of dementia - Neve 1.0 empowers users with a simple, affordable, and non-invasive tool to understand their brain health.
What makes Neve 1.0 unique?
1. Powerful AI Models Built on Real Data
Our advanced machine learning models, developed from pre-collected EEG data, have demonstrated remarkable accuracy in identifying early cognitive decline and other neurological patterns. These models are already proven and ready to deliver real-world impact.
2. A Growing Ecosystem
As data collection progresses, Neve 1.0 will expand its functionalities, unlocking insights into a wide range of mental health conditions. Users can benefit from neurofeedback therapy delivered through the platform, which enhances focus, reduces stress, and improves overall brain health - all from the comfort of home.
3. Accelerating Mental Health Research
Data collected on the Neural Cloud Platform will be securely and anonymously analysed, fueling groundbreaking research into dementia and other neurological conditions. By enabling scalable studies on a global scale, Neve 1.0 has the potential to reshape mental health care and lead to transformative breakthroughs.
4. Cutting-Edge Security
With neural cybersecurity as a core feature, we ensure that every user’s data remains safe while contributing to the greater good of mental health innovation.
5. Partnerships and Progress
Our collaborations with universities, including the University of Lincoln, alongside our patent-pending technology and upcoming publications, demonstrate our commitment to scientific excellence and innovation.
Our Team
Anoop Antony - Founder & CEO
Tony is a neuroscientist with expertise in psychology, cognitive neuroscience, and AI-driven neurotech. With extensive research experience and a vision to revolutionize brain health, he leads our cutting-edge team leveraging neurotechnology and brain-computer interfaces to advance early detection and treatment of neurological conditions. Under his leadership, NeuroX is shaping the future of healthcare and neurotechnology.
Roland Verment - Clinical Lead
Roland’s passion for neuropsychology stems from a desire to bridge the gap between scientific research and real-world applications. Specializing in neurofeedback and neurotechnology, he has witnessed firsthand their transformative impact - helping individuals alleviate symptoms, improve learning, and reduce reliance on medication. Trained extensively in Prague, Basel, and Croatia, Roland remains dedicated to advancing his expertise and staying at the forefront of the field, supported by a strong network of experienced practitioners worldwide.
Dr. Farhan Riaz - Head of Technology & Research
Farhan is a Senior Lecturer at the University of Lincoln and an AI Consultant at Troon Technologies. With expertise in computer vision, biomedical engineering, and research, he brings extensive experience in advanced AI applications. Holding a PhD in Biomedical Engineering, he is skilled in Computer Science, LaTeX, and MATLAB, and is dedicated to innovation and education in the tech field.
Chris Green - Head of Commercial
Chris is a hands-on, professionally qualified (Marketing), internationally experienced, Consultant, Senior Commercial, Partnerships & Client Services Executive with over 25 years’ experience in both public and private service sectors. For the last 6 years he has been working in the field of Mental Health and Corporate Workplace Wellbeing, creating digital products, strategies and partnerships to promote good personal/employee health & wellbeing. He is technically astute and commercially creative, with an entrepreneurial mindset.
Why donate to Neve 1.0?
- Be Part of a Global Revolution: Support the creation of a tool that will change millions of lives by making early dementia screening accessible to all.
- Shape the Future of Mental Health Care: Your donation helps scale an ecosystem that delivers diagnostics, therapy, and research in one unified platform.
- Early Access to Innovation: Supporters will gain direct access to the Neve 1.0 ecosystem and its game-changing technology through our rewards package
- A Strong Team with a Unified Vision: Our team of experienced and up-coming neurotech specialists, engineers, and researchers are driven to better the world through technology and innovation.
Join Us at One of Our Exclusive 'Open Day' Events!
We’re thrilled by the interest and support for Neve 1.0, our groundbreaking new product!
To give you a closer look at who we are and what we stand for, we’re hosting a series of Open Day events to run in parallel with our Crowdfunder project.
This is your opportunity to:
- Meet our passionate team.
- Ask any questions you have about Neve 1.0.
- Get a behind-the-scenes feel for our business, our people, and our authenticity.
We believe in transparency and connection, and we’d love to meet you in person to share our vision and hear your thoughts.
The Open Days will be held at our London clinic on the following dates/times:
Tuesday 21st, 28th January, 4th & 11th February - 11am to 2pm
Thursday 23rd, 30th January, 6th & 13th February - 2pm to 5pm.
Our London clinic address is:
18th Floor, 100 Bishopsgate, London. EC2N 4AG
Drop us an email to [email protected] to let us know which day you'd like to visit so we can monitor numbers and let security know we are expecting you.
Thank you for believing in us and for helping us bring Neve 1.0 to life.
We can’t wait to meet you!